enGene amends, expands $50 million milestone loan facility with Hercules

Chicago, Dec. 22 – enGene Holdings Inc. amended its loan agreement with Hercules Capital, Inc., according to a press release.

Under the loan agreement, enGene borrowed a $22.5 million four-year term loan. Subject to certain clinical and financial milestones, the loan will be expanded a further $27.5 million.

Proceeds will be used for working capital and general corporate purposes, including to refinance the company’s existing debt under the original loan agreement with Hercules from Dec. 30, 2021.

The loan matures Jan. 1, 2028.

enGene is a clinical-stage biotechnology company based in Boston and Montreal.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.